SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Breakthrough Company????? Endovasc ENDV -- Ignore unavailable to you. Want to Upgrade?


To: chalu2 who wrote (2)3/8/1999 8:40:00 AM
From: The Street  Respond to of 94
 
-----Original Message-----
From: nowstockbuy@sdm.net.mx [mailto:nowstockbuy@sdm.net.mx]
Sent: Saturday, March 06, 1999 2:12 PM
To: l_smartinvestorss@sdm.net.mx
Subject: RE: BIOTECH BREAKTHROUGH!

Company: Endovasc Ltd., Inc.
Symbol: E N D V
Price: 1/2 ($.50/share)

The April issue of the British Biotechnology Letter, Oxford,
England,states "scientists at Glaxo Wellcome have proven
the efficacy of Endovasc's PGE-1 and have submitted
to management a multi-million dollar joint venture proposal".

ENDV is recommended as an immediate and "STRONG BUY".

go to:

quote.yahoo.com



lm.